FLT3 and acute myeloid leukemia: Given that genomic instability appears to contribute to the frequent rapid relapses seen in patients with AML with FLT3-ITD [4, 19], incorporation of pan-Pim inhibitors into chemotherapy regimens may be beneficial not only for chemosensitization, but also to decrease genomic instability, and decreased genomic instability may have clinical benefit.